1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TAT CTRPv2 pan-cancer AAC 0.08 0.03
mRNA INTS8 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA CLIC4 CTRPv2 pan-cancer AAC -0.093 0.03
mRNA KHDRBS1 CTRPv2 pan-cancer AAC 0.087 0.03
mRNA POLR3K CTRPv2 pan-cancer AAC 0.086 0.03
mRNA RASSF10 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA ANKRD49 CTRPv2 pan-cancer AAC -0.093 0.03
mRNA RIC8B CTRPv2 pan-cancer AAC 0.086 0.03
mRNA GDI2 CTRPv2 pan-cancer AAC 0.087 0.03
mRNA KCNJ14 CTRPv2 pan-cancer AAC 0.083 0.03
Download CSV